These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1316232)

  • 21. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Major difference in the hepatocarcinogenicity and DNA adduct forming ability between toremifene and tamoxifen in female Crl:CD(BR) rats.
    Hard GC; Iatropoulos MJ; Jordan K; Radi L; Kaltenberg OP; Imondi AR; Williams GM
    Cancer Res; 1993 Oct; 53(19):4534-41. PubMed ID: 8402624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the induction of hepatic peroxisome proliferation by the herbicide oxadiazon in vivo in rats, mice, and dogs and in vitro in rat and human hepatocytes.
    Richert L; Price S; Chesne C; Maita K; Carmichael N
    Toxicol Appl Pharmacol; 1996 Nov; 141(1):35-43. PubMed ID: 8917673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dehydroepiandrosterone-induced peroxisome proliferation in the rat liver.
    Rao MS; Musunuri S; Reddy JK
    Pathobiology; 1992; 60(2):82-6. PubMed ID: 1533303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biological potential of basophilic hepatocellular foci and hepatic adenoma induced by the peroxisome proliferator, Wy-14,643.
    Marsman DS; Popp JA
    Carcinogenesis; 1994 Jan; 15(1):111-7. PubMed ID: 7507413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatocellular carcinomas in acatalasemic mice treated with nafenopin, a hypolipidemic peroxisome proliferator.
    Reddy JK; Rao S; Moody DE
    Cancer Res; 1976 Apr; 36(4):1211-7. PubMed ID: 177202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age-related susceptibility to the carcinogenic effect of the peroxisome proliferator WY-14,643 in rat liver.
    Cattley RC; Marsman DS; Popp JA
    Carcinogenesis; 1991 Mar; 12(3):469-73. PubMed ID: 1849052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dehydroepiandrosterone is a complete hepatocarcinogen and potent tumor promoter in the absence of peroxisome proliferation in rainbow trout.
    Orner GA; Mathews C; Hendricks JD; Carpenter HM; Bailey GS; Williams DE
    Carcinogenesis; 1995 Dec; 16(12):2893-8. PubMed ID: 8603461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of tamoxifen and two of its non-isomerizable fixed-ring analogs on multistage rat hepatocarcinogenesis.
    Dragan YP; Fahey S; Nuwaysir E; Sattler C; Babcock K; Vaughan J; McCague R; Jordan VC; Pitot HC
    Carcinogenesis; 1996 Mar; 17(3):585-94. PubMed ID: 8631149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dehydroepiandrosterone-induced peroxisome proliferation in the rat: evaluation of sex differences.
    Rao MS; Reid B; Ide H; Subbarao V; Reddy JK
    Proc Soc Exp Biol Med; 1994 Nov; 207(2):186-90. PubMed ID: 7938049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose-related effects of the hepatocarcinogen, Wy-14,643, on peroxisomes and cell replication.
    Wada N; Marsman DS; Popp JA
    Fundam Appl Toxicol; 1992 Jan; 18(1):149-54. PubMed ID: 1601204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dietary glycine prevents the development of liver tumors caused by the peroxisome proliferator WY-14,643.
    Rose ML; Cattley RC; Dunn C; Wong V; Li X; Thurman RG
    Carcinogenesis; 1999 Nov; 20(11):2075-81. PubMed ID: 10545408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relevance of peroxisome proliferation and cell proliferation in peroxisome proliferator-induced hepatocarcinogenesis.
    Rao MS; Reddy JK
    Drug Metab Rev; 1989; 21(1):103-10. PubMed ID: 2696631
    [No Abstract]   [Full Text] [Related]  

  • 34. Enhancement and phenotypic modulation of N-nitrosomorpholine-induced hepatocarcinogenesis by dehydroepiandrosterone.
    Metzger C; Bannasch P; Mayer D
    Cancer Lett; 1997 Dec; 121(2):125-31. PubMed ID: 9570349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the enhancing effects of dehydroepiandrosterone with the structural analog 16 alpha-fluoro-5-androsten-17-one on aflatoxin B1 hepatocarcinogenesis in rainbow trout.
    Orner GA; Donohoe RM; Hendricks JD; Curtis LR; Williams DE
    Fundam Appl Toxicol; 1996 Nov; 34(1):132-40. PubMed ID: 8937900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A short-term assessment of tumor-promotion activity in the livers of rats treated with two genotoxic methylating agents: dimethylnitrosamine and methylnitrosourea.
    Asakura S; Daimon H; Sawada S; Sagami F
    Toxicol Lett; 1998 Sep; 98(3):155-67. PubMed ID: 9788584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chlorinated hydrocarbon-induced peroxisomal enzyme activity in relation to species and organ carcinogenicity.
    Goldsworthy TL; Popp JA
    Toxicol Appl Pharmacol; 1987 Apr; 88(2):225-33. PubMed ID: 3564041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The absence of gamma-glutamyl transpeptidase activity in putative preneoplastic lesions and in hepatocellular carcinomas induced in rats by the hypolipidemic peroxisome proliferator Wy-14,643.
    Rao MS; Lalwani ND; Scarpelli DG; Reddy JK
    Carcinogenesis; 1982; 3(10):1231-3. PubMed ID: 6129072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in liver structure and function after short-term and long-term treatment of rats with dehydroepiandrosterone.
    Bellei M; Battelli D; Fornieri C; Mori G; Muscatello U; Lardy H; Bobyleva V
    J Nutr; 1992 Apr; 122(4):967-76. PubMed ID: 1532421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modifying influence of dehydroepiandrosterone on the development of dihydroxy-di-n-propylnitrosamine-initiated lesions in the thyroid, lung and liver of F344 rats.
    Moore MA; Thamavit W; Tsuda H; Sato K; Ichihara A; Ito N
    Carcinogenesis; 1986 Feb; 7(2):311-6. PubMed ID: 2868807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.